1-6 of 6
Nicolas Leupin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial

Martine Bagot, MD PhD, Marie Maerevoet, MD, Pier Luigi Zinzani, MD, Fritz Offner, MD, Franck Morschhauser, MD, Jean-Marie Michot, MD, Vincent Ribrag, MD, Maxime Battistella, MD PhD, Helene Moins, Angelica Calleri, PhD, Stéphane Dalle, MD PhD, Marie Beylot-Barry, MD PhD, Karen Zwaenepoel, PhD, Koen De Winnie, PhD, Anne Marie-Cardine, PhD, Jean-Michel Cayuela, PhD, Valentina Tabanelli, MD, Giovanna Motta, PhD, Federica Melle, PhD, Anna Hultberg, PhD, Domenica Gandini, MD PhD, Teresa Marafioti, MD, Mahan Moshir, MSc, Tim Delahaye, MSc, Piotr Zabrocki, PhD, Karen Silence, PhD, Luc Van Rompaey, PhD, Armand Bensussan, MD PhD, Hans De Haard, PhD, Patrick Pauwels, MD PhD, Nicolas Leupin, MD, Stefano A. Pileri, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1627.
https://doi.org/10.1182/blood-2018-99-118204
Published: 2018
Journal Articles

Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

Adrian F Ochsenbein, MD, Carsten Riether, PhD, Ulrike Bacher, Rouven Müller, MD, Sabine Höpner, PhD, Yara Banz, Magdalena Hinterbrandner, Msc, Mario Bargetzi, MD, Markus G. Manz, MD, Luc Van Rompaey, PhD, Mahan Moshir, MSc, Tim Delahaye, MSc, Domenica Gandini, MD PhD, Ellen Erzeel, Anna Hultberg, PhD, Samson Fung, MD, Hans De Haard, PhD, Nicolas Leupin, MD, Thomas Pabst, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2680.
https://doi.org/10.1182/blood-2018-99-118302
Published: 2018
Journal Articles

Blocking CD70/CD27 Signaling in Combination with Hypomethylating Agents Eradicates Human CD34 + AML Stem and Progenitor Cells in Vitro and In Vivo

Magdalena Hinterbrandner, Msc, Nils Maria Kallen, Ursina Lüthi, Thomas Pabst, MD, Luc Van Rompaey, PhD, Nicolas Leupin, MD, Hans De Haard, PhD, Adrian F Ochsenbein, MD, Carsten Riether, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2652.
https://doi.org/10.1182/blood.V130.Suppl_1.2652.2652
Published: 2017
Journal Articles

Argx-113, a Novel Fc-Based Approach for Antibody-Induced Pathologies Such As Primary Immune Thrombocytopenia

Peter Ulrichts, PhD, Thierry Cousin, MD, Torsten Dreier, PhD, Hans de Haard, PhD, Nicolas Leupin, MD
Journal: Blood
Blood (2016) 128 (22): 4919.
https://doi.org/10.1182/blood.V128.22.4919.4919
Published: 2016
Journal Articles

The Combination of 2-CDA and Rituximab in Patients with Chronic Lymphocytic Leukemia (CLL): A Prospective Multicenter Phase II Trial (SAKK 34/02).

Nicolas Leupin, MD, Jan C. Schuller, PhD, Max Solenthaler, MD, Andre Tichelli, MD, Alois Gratwohl, MD, Kurt Beretta, MD, Mario J. Bargetzi, MD, Andreas Himmelmann, MD, Susanne Hanselmann, PhD, Reinhard Zenhausern, MD
Journal: Blood
Blood (2007) 110 (11): 2057.
https://doi.org/10.1182/blood.V110.11.2057.2057
Published: 2007
Journal Articles

Enhancing Neutrophil Differentiation - A Novel Role for the Death-Associated Protein Kinase 2 (DAPK2).

Mattia Rizzi, MD, Christian Britschgi, MD, Mario P. Tschan, PhD, Tobias J. Grob, MD, PhD, Barbara Huegli, Nicolas Leupin, MD, Beatrice U. Mueller, MD, Andrew Ziemiecki, PhD, Bruce E. Torbett, PhD, Martin F. Fey, MD, Andreas Tobler, MD
Journal: Blood
Blood (2005) 106 (11): 1348.
https://doi.org/10.1182/blood.V106.11.1348.1348
Published: 2005